AEBI three-lens brief
Evidence-based stock research on AEBI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -4.25% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -4.25% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Negative free cash flow last quarterly (-$75.09M).
- Reported earnings on 2026-11-11.
- Ex-dividend date 2026-11-12.
AEBI closed at $10.70 (-4.25%) as of 2026-11-12. Market cap: $829.97M. P/E (trailing) 35.6. Price is below the 50-day MA and below the 200-day MA. Concerns: moved -4.25% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $493.11M, net income $10.81M, free cash flow -$75.09M.
Why three lenses on AEBI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AEBI across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AEBI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AEBI brief"></iframe>